Home
Contact ARYx
Site Map
Search
About ARYx
Mission Statement
Executive Management
Board of Directors
Corporate Presentation
Making Safer Drugs
Product Improvements
Intellectual Property
Products
ATI-7505 - Gastrointestinal Disorders
Budiodarone (ATI-2042) - Atrial Fibrillation
Tecarfarin (ATI-5923) - Anticoagulation
ATI-9242 - Psychiatric Disorders
Future Applications
Partners
Partnering Opportunities
Partnering Information
Investors
Management
Corporate Governance
Press Releases
Events & Presentations
SEC Filings
Stock Performance
Investor FAQs
Contact Us
Careers
Mission Statement
Current Opportunities
Site Map
About ARYx
Mission Statement
Executive Management
Board of Directors
Corporate Presentation
Making Safer Drugs
Product Improvements
Intellectual Property
Products
ATI-7505 - Gastrointestinal Disorders
Budiodarone (ATI-2042) - Atrial Fibrillation
Tecarfarin (ATI-5923) - Anticoagulation
ATI-9242 - Psychiatric Disorders
Future Applications
Partners
Partnering Opportunities
Partnering Information
Investors
Management
Corporate Governance
Press Releases
Events & Presentations
SEC Filings
Stock Performance
Investor FAQs
Contact Us
Careers
Mission Statement
Current Opportunities